Keyword search

Skip to main content
Skip to footer

Language selection

Français

Search and menus

Search and menus

Search

Results

All (67)

All (67) (0 to 10 of 67 results)

1. Access to prescription insurance and medication use during the COVID-19 pandemic among First Nations people living off reserve, Métis and Inuit in the provinces
Articles and reports: 41-20-00022024003
Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.
Release date: 2024-10-15
2. Levels of Drugs in the Wastewater of Canadian Cities
Data Visualization: 71-607-X2024021
Description: This dashboard presents provisional monthly estimates of the levels of amphetamine, cannabis, cocaine (benzoylecgonine), codeine, fentanyl (norfentanyl), ecstasy, methadone, methamphetamine, morphine, and oxycodone in the wastewater of Halifax, Montréal, Toronto, Saskatoon, Prince Albert, Edmonton, and Metro Vancouver. The data that are relevant for monitoring the use of these substances in Canadian cities.
Release date: 2024-09-06
3. A snapshot of the health of Canadians
Stats in brief: 11-627-M2023066
Description: The Health of Canadians infographic aims to provide a snapshot into the population health of Canadians by highlighting health data from the annual report. It includes key statistics on population health such as health outcomes (e.g., chronic conditions), health behaviours (e.g., smoking and alcohol consumption) and access to health care.
Release date: 2023-11-29
4. Characterizing polysubstance use: What do we know about use of cigarettes, vaping products, cannabis, and alcohol among Canadians?
Articles and reports: 82-003-X202300400002
Description: Polysubstance use—the use of multiple substances on the same or different occasions—is a risk factor for substance use disorder. However, national surveillance of substance use in Canada has often focused on use of a single substance. To better understand and address polysubstance use, this study characterized the use of vaping products, cigarettes, inhaled cannabis, and alcohol among Canadians aged 15 years and older. Nationally representative data from the 2020 Canadian Tobacco and Nicotine Survey were analyzed.
Release date: 2023-04-19
5. Exploring the intersectionality of characteristics among those who experienced opioid overdoses: A cluster analysis
Articles and reports: 82-003-X202300300001
Description: As Canada continues to experience an opioid crisis, it is important to understand the intersection between the demographic, socioeconomic and service use characteristics of those experiencing opioid overdoses to better inform prevention and treatment programs. This study aims to identify distinct groups of individuals with unique sets of characteristics and experiences among those who had an opioid overdose in British Columbia between 2014 and 2016.
Release date: 2023-03-15
6. Pharmaceutical access and use during the pandemic
Articles and reports: 75-006-X202200100011
Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.
Release date: 2022-11-02
7. Medical and non-medical cannabis use in Canada, 2019/2020 Archived
Stats in brief: 11-627-M2022054
Description:
An analysis of medical and non-medical cannabis consumption in the past 12 months among the population aged 15 or older, using the 2019/2020 Canadian Community Health Survey.

Release date: 2022-10-17
8. Risk of non-medical drug overdose following prescription of opioids post-injury: A retrospective cohort study
Articles and reports: 82-003-X202200700001
Description:
There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

Release date: 2022-07-20
9. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians
Articles and reports: 82-003-X202200600001
Description:
Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

Release date: 2022-06-15
10. Significant factors associated with problematic use of opioid pain relief medications among the household population, Canada, 2018
Articles and reports: 82-003-X202101200002
Description:
Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

Release date: 2022-01-19

Data (6)

Data (6) ((6 results))

1. Levels of Drugs in the Wastewater of Canadian Cities
Data Visualization: 71-607-X2024021
Description: This dashboard presents provisional monthly estimates of the levels of amphetamine, cannabis, cocaine (benzoylecgonine), codeine, fentanyl (norfentanyl), ecstasy, methadone, methamphetamine, morphine, and oxycodone in the wastewater of Halifax, Montréal, Toronto, Saskatoon, Prince Albert, Edmonton, and Metro Vancouver. The data that are relevant for monitoring the use of these substances in Canadian cities.
Release date: 2024-09-06
2. Canadian Alcohol and Drugs Survey: Public Use Microdata File
Public use microdata: 13-25-0005
Description:
This public use microdata file (PUMF) is from the Canadian Alcohol and Drugs Survey and includes information about the use of substances, including alcohol, cannabis and other drugs. This product is for users who prefer to do their own analysis by focusing on specific subgroups in the population or by cross-classifying variables that were not the focus of our release in The Daily. This product is also available using Statistics Canada's electronic file transfer service. For more information about this survey (questionnaires, definitions, data sources and methods used): Canadian Alcohol and Drugs Survey Occasionally, files such as these require updates. Please re-visit this page to verify if more recent versions are available. Reference period 2019: CSV | SAS | SPSS | STATA.

Release date: 2021-12-24
3. Canadian Perspectives Survey Series 6: Substance Use and Stigma During the Pandemic Public Use Microdata File
Public use microdata: 45-25-0012
Description:
This public use microdata file is from the sixth survey in the Canadian Perspectives Survey Series and includes information about the use of substances, including alcohol, cannabis, opioids and non-prescription substances during the pandemic. This product is provided using Statistics Canada's electronic file transfer service.

Release date: 2021-04-12
4. International Youth Survey Archived
Public use microdata: 89M0024X
Geography: Census metropolitan area
Description:
The International Youth Survey (IYS) is the Canadian portion of the International Self-Report Delinquency Study (ISRD) which examines the behaviour and misbehaviour of students in grades 7 to 9 in about 30 European countries, United States and Canada. The National Crime Prevention Centre of the federal department of Public Safety sponsored the Canadian survey. The city of Toronto was chosen as the most suitable city where Statistics Canada could conduct the survey and on which the analysis of results would focus.
The survey needed to be representative of each of the three grades (7 to 9) and at the grade level, of both sexes. In April 2006, about 3,200 students in 176 schools completed the IYS.
Release date: 2007-09-25
5. National Population Health Survey - Public Use Microdata Files - Household Component Archived
Public use microdata: 82M0009X
Description:
The National Population Health Survey (NPHS) used the Labour Force Survey sampling frame to draw the initial sample of approximately 20,000 households starting in 1994 and for the sample top-up this third cycle. The survey is conducted every two years. The sample collection is distributed over four quarterly periods followed by a follow-up period and the whole process takes a year. In each household, some limited health information is collected from all household members and one person in each household is randomly selected for a more in-depth interview.
The survey is designed to collect information on the health of the Canadian population and related socio-demographic information. The first cycle of data collection began in 1994, and continues every second year thereafter. The survey is designed to produce both cross-sectional and longitudinal estimates. The questionnaires includes content related to health status, use of health services, determinants of health, a health index, chronic conditions and activity restrictions. The use of health services is probed through visits to health care providers, both traditional and non-traditional, and the use of drugs and other mediciations. Health determinants include smoking, alcohol use and physical activity. A special focus content for this cycle includes family medical history with questions about certain chronic conditions among immediate family members and when they were acquired. As well, a section on self care has also been included this cycle. The socio-demographic information includes age, sex, education, ethnicity, household income and labour force status.
Release date: 2000-12-19
6. Canada's Alcohol and Other Drugs Survey - Documentation and Data Files Archived
Public use microdata: 89M0007X
Description:
Information in this microdata file refers to survey data collected in September - November, 1994 for persons 15 years of age and older in Canada's ten provinces. The survey's main data objectives were to measure the prevalence and patterns of alcohol and other drug use, to assess harm and other consequences of drug use and to evaluate trends in recent patterns of use. Canada's Alcohol and Other Drugs Survey (CADS) also updates and expands upon data collected in the first survey, the National Alcohol and Other Drugs Survey (NADS), conducted in 1989.
Release date: 2000-07-07

Analysis (61)

Analysis (61) (0 to 10 of 61 results)

1. Access to prescription insurance and medication use during the COVID-19 pandemic among First Nations people living off reserve, Métis and Inuit in the provinces
Articles and reports: 41-20-00022024003
Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.
Release date: 2024-10-15
2. A snapshot of the health of Canadians
Stats in brief: 11-627-M2023066
Description: The Health of Canadians infographic aims to provide a snapshot into the population health of Canadians by highlighting health data from the annual report. It includes key statistics on population health such as health outcomes (e.g., chronic conditions), health behaviours (e.g., smoking and alcohol consumption) and access to health care.
Release date: 2023-11-29
3. Characterizing polysubstance use: What do we know about use of cigarettes, vaping products, cannabis, and alcohol among Canadians?
Articles and reports: 82-003-X202300400002
Description: Polysubstance use—the use of multiple substances on the same or different occasions—is a risk factor for substance use disorder. However, national surveillance of substance use in Canada has often focused on use of a single substance. To better understand and address polysubstance use, this study characterized the use of vaping products, cigarettes, inhaled cannabis, and alcohol among Canadians aged 15 years and older. Nationally representative data from the 2020 Canadian Tobacco and Nicotine Survey were analyzed.
Release date: 2023-04-19
4. Exploring the intersectionality of characteristics among those who experienced opioid overdoses: A cluster analysis
Articles and reports: 82-003-X202300300001
Description: As Canada continues to experience an opioid crisis, it is important to understand the intersection between the demographic, socioeconomic and service use characteristics of those experiencing opioid overdoses to better inform prevention and treatment programs. This study aims to identify distinct groups of individuals with unique sets of characteristics and experiences among those who had an opioid overdose in British Columbia between 2014 and 2016.
Release date: 2023-03-15
5. Pharmaceutical access and use during the pandemic
Articles and reports: 75-006-X202200100011
Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.
Release date: 2022-11-02
6. Medical and non-medical cannabis use in Canada, 2019/2020 Archived
Stats in brief: 11-627-M2022054
Description:
An analysis of medical and non-medical cannabis consumption in the past 12 months among the population aged 15 or older, using the 2019/2020 Canadian Community Health Survey.

Release date: 2022-10-17
7. Risk of non-medical drug overdose following prescription of opioids post-injury: A retrospective cohort study
Articles and reports: 82-003-X202200700001
Description:
There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

Release date: 2022-07-20
8. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians
Articles and reports: 82-003-X202200600001
Description:
Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

Release date: 2022-06-15
9. Significant factors associated with problematic use of opioid pain relief medications among the household population, Canada, 2018
Articles and reports: 82-003-X202101200002
Description:
Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

Release date: 2022-01-19
10. Impaired driving in Canada, 2019
Articles and reports: 85-002-X202100100012
Description:
Using data from the Uniform Crime Reporting Survey (UCR), this Juristat article presents data on police-reported impaired driving, including data specific to drug-impaired driving. More precisely, it examines the trends of impaired driving in Canada, the provinces and territories and in Census metropolitan areas. Characteristics of impaired driving, such as age and sex of accused persons and time of the day or time of the year when those incidents occur, are also examined. This Juristat article also presents data on impaired driving cases completed by criminal courts, including comparisons between alcohol and drug-impaired cases.
Release date: 2021-07-15

Reference (0)

Reference (0) (0 results)

No content available at this time.

Report a problem or mistake on this page

Date modified:: 2025-04-29